EUVIMEDEUVIMED entdecken
Open Access

Aberrant ALPP Expression Serves as a Prognostic Biomarker and Facilitates Cholangiocarcinoma Progression through Immune Evasion and PI3K-Akt Signaling Activation

Guo-Wei Wu, Yi-Chung Chien, Li-Yuan Bai, Yung-Luen Yu

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.116260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Guo-Wei Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, China Medical University, Taichung 406040, Taiwan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Biomarkers, Tumor, Bile Duct Neoplasms, Alkaline Phosphatase. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBiomarkers, TumorBile Duct NeoplasmsAlkaline PhosphataseHumansPrognosisProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesMaleFemaleGene Expression Regulation, NeoplasticMiddle AgedDisease ProgressionDendritic CellsDNA MethylationLymphocytes, Tumor-InfiltratingTumor MicroenvironmentB-LymphocytesAntigens, Tumor-Associated, CarbohydrateImmune Evasion

Stichwörter der Autor:innen

ALPPCA19-9PI3K-Akt pathwaycholangiocarcinomatumor-infiltrating immune cells

Substanzen

Biomarkers, TumorProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesAlkaline Phosphatasecarbohydrate antigen 199, humanAntigens, Tumor-Associated, Carbohydrate

Autor:innen und Institutionen

  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung 406040, Taiwan.
  • Institute of Translational Medicine and New Drug Development, China Medical University, Taichung 406040, Taiwan.
  • Center for Molecular Medicine, China Medical University Hospital, Taichung 404327, Taiwan.
  • Department of Hematology and Oncology, China Medical University Hospital, Taichung 404327, Taiwan.
  • Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung 406040, Taiwan.
  • Office of Research and Development, Asia University, Taichung 41354, Taiwan.

Zitieren

APA

Wu, G. W., Chien, Y. C., Bai, L. Y., & Yu, Y. L. (2025). Aberrant ALPP Expression Serves as a Prognostic Biomarker and Facilitates Cholangiocarcinoma Progression through Immune Evasion and PI3K-Akt Signaling Activation. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.116260

Vancouver

Wu GW, Chien YC, Bai LY, Yu YL. Aberrant ALPP Expression Serves as a Prognostic Biomarker and Facilitates Cholangiocarcinoma Progression through Immune Evasion and PI3K-Akt Signaling Activation. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.116260

BibTeX
@article{Wu2025,
  author = {Wu, Guo-Wei and Chien, Yi-Chung and Bai, Li-Yuan and Yu, Yung-Luen},
  title = {Aberrant ALPP Expression Serves as a Prognostic Biomarker and Facilitates Cholangiocarcinoma Progression through Immune Evasion and PI3K-Akt Signaling Activation},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.116260}
}
Kostenlos starten →